BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang J, Hu X, Hu X, Gao F, Li M, Cui Y, Wei X, Qin Y, Zhang C, Zhao Y, Gao Y. MicroRNA-520c-3p targeting of RelA/p65 suppresses atherosclerotic plaque formation. Int J Biochem Cell Biol 2021;131:105873. [PMID: 33166679 DOI: 10.1016/j.biocel.2020.105873] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Li X, Yang Y, Wang Z, Jiang S, Meng Y, Song X, Zhao L, Zou L, Li M, Yu T. Targeting non-coding RNAs in unstable atherosclerotic plaques: Mechanism, regulation, possibilities, and limitations. Int J Biol Sci 2021;17:3413-27. [PMID: 34512156 DOI: 10.7150/ijbs.62506] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
2 Hong Z, Zhang T, Zhang Y, Xie Z, Lu Y, Yao Y, Yang Y, Wu H, Liu B. Reveals of candidate active ingredients in Justicia and its anti-thrombotic action of mechanism based on network pharmacology approach and experimental validation. Sci Rep 2021;11:17187. [PMID: 34433871 DOI: 10.1038/s41598-021-96683-z] [Reference Citation Analysis]
3 Kowara M, Cudnoch-Jedrzejewska A. Different Approaches in Therapy Aiming to Stabilize an Unstable Atherosclerotic Plaque. Int J Mol Sci 2021;22:4354. [PMID: 33919446 DOI: 10.3390/ijms22094354] [Reference Citation Analysis]
4 Kowara M, Borodzicz-Jazdzyk S, Rybak K, Kubik M, Cudnoch-Jedrzejewska A. Therapies Targeted at Non-Coding RNAs in Prevention and Limitation of Myocardial Infarction and Subsequent Cardiac Remodeling-Current Experience and Perspectives. Int J Mol Sci 2021;22:5718. [PMID: 34071976 DOI: 10.3390/ijms22115718] [Cited by in F6Publishing: 1] [Reference Citation Analysis]